Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Trading Update

8 Feb 2019 07:00

RNS Number : 4379P
GLI Finance Limited
08 February 2019
 

8 February 2019

 GLI Finance Limited("the Group")

Trading Update

GLI Finance today announces a trading update.

Sancus BMS

The Group's core business, Sancus BMS Group Limited ("Sancus BMS"), continues to grow, with revenue for the year ended 31 December 2018 ("FY18") expected to be approximately £13 million, representing a 28% increase over the prior year. The Group also generated record loan origination levels in FY18 (approximately £168 million of funding, representing a 21% increase over the prior year). 

Sancus Finance Limited ("Sancus Finance"), a subsidiary of the Group which operates its supply chain finance offering in the UK, remains loss making and while its performance improved in 2018, it is behind management's expectations with a forecast operating loss of £1 million. The Group believes the market for supply chain finance has changed significantly, with credit insurers reducing appetite to write cover and increasing premiums markedly. In light of this, and recognising the difficult market conditions facing supply chain finance more generally, the Group has taken the decision to close its supply chain finance offering. The Group also has a £1.1 million exposure to a supply chain finance borrower which recently went into administration and the Group will prudently recognise a provision in respect of its full exposure in FY18.

Sancus BMS's remaining operations in the UK will continue to provide education funding and asset backed lending. More broadly, the Group remains focussed on the core asset backed lending offering in the 6 jurisdictions in which it operates. Sancus BMS recently surpassed a £1 billion total lending milestone and, with a very strong pipeline and a proprietary electronic platform, the business is well placed to achieve further scale.

Fintech Ventures

The Group also announces that it expects to suffer further material write downs in its Fintech Ventures portfolio. It has recently become apparent that several of the platforms are finding it harder to raise further capital at the valuation levels previously expected. Those that successfully raised further capital in 2018 are better placed to execute on their long-term business plans but this has, in some cases, resulted in a significant dilution for GLI.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014.

GLI Finance

+44 (0)1534 708900

Andy Whelan

 

 

 

Nominated Adviser and Broker

 

Liberum Capital Limited

+44 (0)203 100 2000

Chris ClarkeSteve Pearce

 

Trystan Cullen

 

 

 

Public Relations Adviser

 

Instinctif Partners

+44 (0)207 457 2020

Tim Linacre

 

Katie Bairsto

 

 

 

LEI: 213800S2XOO3YSEGCA26

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSMEEWFUSEDE
Date   Source Headline
20th Apr 20167:00 amRNS2016 First Interim Dividend
20th Apr 20167:00 amRNSFurther investment in Platform Black
5th Apr 20167:00 amRNSBMS Finance launches ?30m Irish SME debt fund
1st Apr 20168:32 amRNSTotal Voting Rights
30th Mar 20162:20 pmRNSPublication of Annual Report & Notice of AGM
29th Mar 20167:00 amRNSConsolidated Results for The Year Ended 31.12.2015
23rd Mar 20163:34 pmRNSDirector/PDMR Shareholding
21st Mar 20167:00 amRNSScrip Dividend Shares
17th Mar 20161:58 pmRNSDesignation for the Bank Referral Scheme
17th Mar 20167:00 amRNSNew Credit Facility
8th Mar 201610:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
8th Mar 201610:39 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
4th Mar 201611:24 amRNSCompletion of GLIAF share sale
3rd Mar 20165:22 pmRNSHolding(s) in Company
25th Feb 20161:00 pmRNSResult of Extraordinary General Meeting
16th Feb 20167:00 amRNSConfirmation of CEO Strategic Review & NAV Update
8th Feb 20167:00 amRNSProposed fundraising and notice of EGM
29th Jan 20167:00 amRNSTotal Voting Rights
21st Jan 20167:00 amRNS2015 Fourth Interim Dividend
20th Jan 20164:55 pmRNSIssue of Ordinary Shares
7th Jan 20165:04 pmRNSDirector/PDMR Shareholding
6th Jan 20164:21 pmRNSHolding(s) in Company
6th Jan 20164:16 pmRNSHolding(s) in Company
4th Jan 20165:03 pmRNSHolding(s) in Company
4th Jan 201612:00 pmRNSHolding(s) in Company
4th Jan 201610:57 amRNSHolding(s) in Company
31st Dec 201512:46 pmRNSDirector/PDMR Shareholding
24th Dec 201510:39 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
22nd Dec 20159:49 amRNSHolding(s) in Company
21st Dec 20157:00 amRNSRe placing, offer, Board changes and other events
10th Dec 20157:00 amRNSUpdate on convertible unsecured bonds
8th Dec 20154:06 pmRNSApnt of Alternate Director /interim Audit Co Chair
7th Dec 201512:11 pmRNSDirector/PDMR Shareholding
3rd Dec 20153:52 pmRNSProposed Placing and Open Offer
26th Nov 20157:00 amRNSNAV update
17th Nov 20157:00 amRNSTrading and financial update
13th Nov 20153:40 pmRNSCorrection to total voting rights
22nd Oct 201510:01 amRNSTransaction in Own Shares
19th Oct 20157:00 amRNSQ3 Interim Dividend
8th Oct 201512:00 pmRNSTransfer of loans to GLI Alternative Finance plc
28th Sep 20155:04 pmRNSPublication of Prospectus
28th Sep 20157:00 amRNSGLI Finance Limited Interim Results 2015
25th Sep 20154:48 pmRNSHolding(s) in Company
22nd Sep 20157:00 amRNSLaunch of a closed end fund
21st Sep 20152:00 pmRNSDirector/PDMR Shareholding
17th Sep 20157:00 amRNSListing scrip div shares
1st Sep 20157:04 amRNSCompletion of increased Platform Black investment
28th Aug 20157:00 amRNSNet Asset Value
31st Jul 20159:27 amRNSHolding(s) in Company
31st Jul 20158:21 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.